PTC THERAPEUTICS, INC. — Director's Dealing 2014

Mar 24, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2014-03-21

Reporting Person: SOUTHWELL DAVID P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-21	Common Stock	S	1200	$30.54	Disposed	12038	Direct
2014-03-21	Common Stock	S	1117	$31.35	Disposed	10921	Direct

Footnotes

F1: The sale transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on August 23, 2013 for the primary purpose of covering tax obligations associated with a restricted stock vesting event.

F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $30.25 to $31.21 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $31.27 to $31.44 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.